This guideline covers stop smoking interventions and services delivered in primary care and community settings for everyone over the age of 12. It aims to ensure that everyone who smokes is advised and encouraged to stop and given the support they need. It emphasises the importance of targeting vulnerable groups who find smoking cessation hard or who smoke a lot.
This guideline includes recommendations on:
- commissioning and providing stop smoking interventions and services
- monitoring stop smoking services
- evidence-based stop smoking interventions
- engaging with people who smoke
- advice on e-cigarettes
- people who want to quit
- people who are not ready to quit
- telephone quitlines
- education and training
- campaigns to promote awareness of local stop smoking services
- closed institutions
Who is it for?
- Commissioners and providers of stop smoking interventions or services, including those in the voluntary and community sectors who have a role or responsibility for this
- Health, social care and other frontline staff with links to stop smoking services who engage with people who smoke
- Health and wellbeing boards
- Members of the public who want to stop smoking or who want to help others to stop
Is this guideline up to date?
We checked this guideline in October 2020 and are we are updating it.
Guideline development process
NICE worked with Public Health England to develop this guidance.
This guideline updates and replaces NICE guidelines PH1 (March 2006) and PH10 (February 2008).
The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, professionals and practitioners are expected to take this guideline fully into account, alongside the individual needs, preferences and values of their patients or the people using their service. It is not mandatory to apply the recommendations, and the guideline does not override the responsibility to make decisions appropriate to the circumstances of the individual, in consultation with them and their families and carers or guardian.
All problems (adverse events) related to a medicine or medical device used for treatment or in a procedure should be reported to the Medicines and Healthcare products Regulatory Agency using the Yellow Card Scheme.
Local commissioners and providers of healthcare have a responsibility to enable the guideline to be applied when individual professionals and people using services wish to use it. They should do so in the context of local and national priorities for funding and developing services, and in light of their duties to have due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities. Nothing in this guideline should be interpreted in a way that would be inconsistent with complying with those duties.
Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible.